EUVIMEDEUVIMED entdecken
Crossref

Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets

Thaís Moré Milan, Ana Patrícia Espaladori Eskenazi, Lucas Dias de Oliveira, Gabriel da Silva, Rayana Longo Bighetti-Trevisan, Gileade Pereira Freitas, Luciana Oliveira Almeida

Cellular Signalling · 2023

DOI: 10.1016/j.cellsig.2023.110773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2023. Verfasst von Thaís Moré Milan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil; Department of Clini…. Hauptthemen laut MEDLINE: Cisplatin, Head and Neck Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Wnt/β-catenin signaling pathway is associated with the regulation of cancer stem cells, and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic modifications involved in the control of the Wnt/β-catenin signaling and investigate the role of this pathway in the accumulation of cancer stem cells (CSC) and chemoresistance of Head and Neck Squamous Cell Carcinoma (HNSCC). Quantitative-PCR, western blot, shRNA assay, viability assay, flow cytometry assay, spheres formation, xenograft model, and chromatin immunoprecipitation were employed to evaluate the Wnt/β-catenin pathway and EZH2 in wild-type and chemoresistant oral carcinoma cell lines, and in the populations of CSC and non-stem cells. We demonstrated that β-catenin and EZH2 were accumulated in cisplatin-resistant and CSC population. The upstream genes of the Wnt/β-catenin signaling (APC and GSK3β) were decreased, and the downstream gene MMP7 was increased in the chemoresistant cell lines. The inhibition of β-catenin and EZH2 combined effectively decreased the CSC population in vitro and reduced the tumor volume and CSC population in vivo. EZH2 inhibition increased APC and GSK3β, and the Wnt/β-catenin inhibition reduced MMP7 levels. In contrast, EZH2 overexpression decreased APC and GSK3β and increased MMP7. EZH2 and β-catenin inhibitors sensitized chemoresistant cells to cisplatin. EZH2 and H3K27me3 bounded the promoter of APC, leading to its repression. These results suggest that EZH2 regulates β-catenin by inhibiting the upstream gene APC contributing to the accumulation of cancer stem cells and chemoresistance. Moreover, the pharmacological inhibition of the Wnt/β-catenin combined with EZH2 can be an effective strategy for treating HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and Neckbeta CateninGlycogen Synthase Kinase 3 betaMatrix Metalloproteinase 7Cell Line, TumorWnt Signaling PathwayNeoplastic Stem CellsGene Expression Regulation, NeoplasticEnhancer of Zeste Homolog 2 Protein

Stichwörter der Autor:innen

ChemoresistanceEZH2Epigenetic modificationsHead and neck carcinomaWnt/β-catenin signaling pathwaycancer stem cells

Substanzen

Cisplatinbeta CateninGlycogen Synthase Kinase 3 betaMatrix Metalloproteinase 7EZH2 protein, humanEnhancer of Zeste Homolog 2 Protein

Autor:innen und Institutionen

  • Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil; Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical S…
  • Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: anaespaladori@usp.br.
  • Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: lucasdiasoli@usp.br.
  • Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: dasilva.gabriel@usp.br.
  • Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: rayana.bighetti@usp.br.
  • Departament of Oral and Maxillofacial Surgery, School of Dentistry, Federal University of Goiás, Goiás, Brazil. Electronic address: gileade@ufg.br.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Milan, T. M., Eskenazi, A. P. E., Oliveira, L. D., Silva, G. D., Bighetti-Trevisan, R. L., Freitas, G. P., & Almeida, L. O. (2023). Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2023.110773

Vancouver

Milan TM, Eskenazi APE, Oliveira LD, Silva GD, Bighetti-Trevisan RL, Freitas GP, et al. Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets. Cellular Signalling. 2023. doi:10.1016/j.cellsig.2023.110773

BibTeX
@article{Milan2023,
  author = {Milan, Thaís Moré and Eskenazi, Ana Patrícia Espaladori and Oliveira, Lucas Dias de and Silva, Gabriel da and Bighetti-Trevisan, Rayana Longo and Freitas, Gileade Pereira and Almeida, Luciana Oliveira},
  title = {Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets},
  journal = {Cellular Signalling},
  year = {2023},
  doi = {10.1016/j.cellsig.2023.110773}
}
Kostenlos starten →